Showing results (1131-1140 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|November 29, 2023
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastomaTracy T Batchelor, Minhee Won, Arnab Chakravarti, et al.
Neuro-Oncology Advances|November 15, 2023
Physician, patient, and caregiver support for a formal certification in pediatric neuro-oncology: A survey-based report from the SNO pediatrics working groupHolly B Lindsay, Sylvia Cheng, Paul Graham Fisher, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
Neuro-Oncology Advances|January 15, 2024
Comparison of volumetric and 2D-based response methods in the PNOC-001 pediatric low-grade glioma clinical trialMarc von Reppert, Divya Ramakrishnan, Sarah C Brüningk, et al.
Neuro-Oncology Advances|January 8, 2024
Growth dynamics of untreated meningiomasPer Sveino Strand, Kathrine Jørgensen Wågø, André Pedersen, et al.
Neuro-Oncology Advances|December 22, 2023
Genomic landscape and actionable mutations of brain metastases derived from non-small cell lung cancer: A systematic reviewLily J Andrews, Zak A Thornton, Ruqiya Saleh, et al.
Neuro-Oncology Advances|December 22, 2023
Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastomaSabbir Khan, Emmanuel Martinez-Ledesma, Jianwen Dong, et al.
Neuro-Oncology Advances|December 18, 2023
Direct image to subtype prediction for brain tumors using deep learningKatherine J Hewitt, Chiara M L Löffler, Hannah Sophie Muti, et al.
Neuro-Oncology Advances|April 1, 2024
Tumor-treating fields dosimetry in glioblastoma: Insights into treatment planning, optimization, and dose-response relationshipsNikola Mikic, Nichal Gentilal, Fang Cao, et al.
Neuro-Oncology Advances|April 1, 2024
State of the neoadjuvant therapy for glioblastoma multiforme-Where do we stand?Naeim Nabian, Reza Ghalehtaki, Mehdi Zeinalizadeh, et al.
Pageof 135